PE20001051A1 - Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides - Google Patents
Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroidesInfo
- Publication number
- PE20001051A1 PE20001051A1 PE1999000910A PE00091099A PE20001051A1 PE 20001051 A1 PE20001051 A1 PE 20001051A1 PE 1999000910 A PE1999000910 A PE 1999000910A PE 00091099 A PE00091099 A PE 00091099A PE 20001051 A1 PE20001051 A1 PE 20001051A1
- Authority
- PE
- Peru
- Prior art keywords
- otitis media
- corticosteroids
- compositions
- methods
- related disorders
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000009890 sinusitis Diseases 0.000 title abstract 2
- 206010033078 Otitis media Diseases 0.000 title 1
- 229960001334 corticosteroids Drugs 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 239000000872 buffer Substances 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 208000022760 infectious otitis media Diseases 0.000 abstract 1
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15084798A | 1998-09-10 | 1998-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001051A1 true PE20001051A1 (es) | 2000-10-17 |
Family
ID=22536243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000910A PE20001051A1 (es) | 1998-09-10 | 1999-09-09 | Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando corticosteroides |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR022084A1 (zh) |
| AU (1) | AU6018999A (zh) |
| CO (1) | CO5160268A1 (zh) |
| MY (1) | MY133181A (zh) |
| PA (1) | PA8481701A1 (zh) |
| PE (1) | PE20001051A1 (zh) |
| TW (1) | TW589185B (zh) |
| WO (1) | WO2000015234A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| PE20060489A1 (es) * | 2004-08-13 | 2006-06-19 | Schering Plough Ltd | Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticosteroide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061729A (en) * | 1988-06-08 | 1991-10-29 | Biogal Gyogyszergyar | Pharmaceutical composition and process for preparing the same |
| HU213401B (en) * | 1990-09-10 | 1997-06-30 | Schering Corp | Process for producing mometasone furoate monohydrate and pharmaceutical composition containing it |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
-
1999
- 1999-08-16 MY MYPI99003509A patent/MY133181A/en unknown
- 1999-09-09 PE PE1999000910A patent/PE20001051A1/es not_active Application Discontinuation
- 1999-09-09 TW TW088115545A patent/TW589185B/zh not_active IP Right Cessation
- 1999-09-09 AR ARP990104541A patent/AR022084A1/es unknown
- 1999-09-09 CO CO99057225A patent/CO5160268A1/es unknown
- 1999-09-09 WO PCT/US1999/018840 patent/WO2000015234A1/en active Application Filing
- 1999-09-09 AU AU60189/99A patent/AU6018999A/en not_active Abandoned
- 1999-09-09 PA PA19998481701A patent/PA8481701A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO5160268A1 (es) | 2002-05-30 |
| TW589185B (en) | 2004-06-01 |
| AU6018999A (en) | 2000-04-03 |
| WO2000015234A1 (en) | 2000-03-23 |
| MY133181A (en) | 2007-10-31 |
| AR022084A1 (es) | 2002-09-04 |
| PA8481701A1 (es) | 2000-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ513810A (en) | Compositions and methods for improved delivery of hydrophobic therapeutic agents | |
| ES2095566T3 (es) | Suspension farmaceutica acuosa para agentes activos farmaceuticos. | |
| WO2001089496A3 (en) | Compositions and methods for treating otic, ophthalmic and nasal infections comprising quinolone antibiotics | |
| BG105379A (en) | Pharmaceutical compositions for the treatment of acute disorders | |
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| BG103127A (en) | Pharmaceutical composition based on water | |
| IL162214A (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
| CA2342211A1 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
| MX9605650A (es) | Formulaciones de propionato de fluticasona. | |
| WO2001072721A3 (en) | Synergistic methods and compositions for treating cancer | |
| WO2000018388A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
| BR9810312A (pt) | Composição farmacêutica que apresenta atividade antitumoral acentuada e/ou efeitos colaterais reduzidos contendo um agente antitumoral e um derivado do ácido hidroxìmico | |
| BRPI0416752A (pt) | composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica | |
| BR0012387A (pt) | Composição para tratamento de distúrbios de secreção externa | |
| AU7096201A (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
| PT1906916E (pt) | Suspensão oftálmica compreendendo um fármaco oftálmico, uma poloxamina e um agente de ajuste da tonicidade de glicol, utilização da referida composição para a produção de um medicamento para o tratamento de distúrbios oftálmicos | |
| BR9809022A (pt) | Composições antiinflamatórias nasais tópicas | |
| HK1038692A1 (zh) | 治療眼、耳、鼻病症的抗生素合成劑 | |
| NO20075758L (no) | Polymorfer av 3-0-(3',3'-dimetylsuccinyl) betulin syre di-N-metyl-D-glukamin | |
| AU5170400A (en) | Topical application of muscarinic and opioid agents for treatment of tinnitus | |
| BR9912556A (pt) | Triazolpiridinas para o tratamento de distúrbios trombóticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |